Details for Patent: 9,750,684
✉ Email this page to a colleague
Which drugs does patent 9,750,684 protect, and when does it expire?
Patent 9,750,684 protects ZERVIATE and is included in one NDA.
This patent has twenty-three patent family members in seven countries.
Summary for Patent: 9,750,684
Title: | Ophthalmic formulations of cetirizine and methods of use |
Abstract: | The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye. |
Inventor(s): | Abelson; Mark Barry (Andover, MA), Chapin; Matthew J. (Amesbury, MA), Gomes; Paul (Andover, MA), Minno; George (Windham, NH), Nice; Jackie (Medford, MA) |
Assignee: | Nicox Ophthalmics, Inc. (Fort Worth, TX) |
Application Number: | 14/982,258 |
Patent Claim Types: see list of patent claims | Formulation; Compound; |
Drugs Protected by US Patent 9,750,684
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,750,684
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2755679 | ⤷ Try a Trial | |||
European Patent Office | 2408453 | ⤷ Try a Trial | |||
European Patent Office | 2547340 | ⤷ Try a Trial | |||
European Patent Office | 3943069 | ⤷ Try a Trial | |||
Spain | 2910374 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |